These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18940185)
1. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma. Jost MM; Lamerz J; Tammen H; Menzel C; De Meester I; Lambeir AM; Augustyns K; Scharpé S; Zucht HD; Rose H; Jürgens M; Schulz-Knappe P; Budde P Biochem Pharmacol; 2009 Jan; 77(2):228-37. PubMed ID: 18940185 [TBL] [Abstract][Full Text] [Related]
2. ASP4000, a slow-binding dipeptidyl peptidase 4 inhibitor, has antihyperglycemic activity of long duration in Zucker fatty rats. Tanaka-Amino K; Matsumoto K; Hatakeyama Y; Takakura S; Mutoh S Acta Diabetol; 2010 Mar; 47(1):43-8. PubMed ID: 19238312 [TBL] [Abstract][Full Text] [Related]
3. Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors--a proof of concept study. Tammen H; Hess R; Rose H; Wienen W; Jost M Peptides; 2008 Dec; 29(12):2188-95. PubMed ID: 18804500 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile). Brandt I; Joossens J; Chen X; Maes MB; Scharpé S; De Meester I; Lambeir AM Biochem Pharmacol; 2005 Jul; 70(1):134-43. PubMed ID: 15907807 [TBL] [Abstract][Full Text] [Related]
5. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors. Zhao G; Taunk PC; Magnin DR; Simpkins LM; Robl JA; Wang A; Robertson JG; Marcinkeviciene J; Sitkoff DF; Parker RA; Kirby MS; Hamann LG Bioorg Med Chem Lett; 2005 Sep; 15(18):3992-5. PubMed ID: 16046120 [TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV activity in the blood of the American alligator (Alligator mississippiensis). Merchant M; Monroe C; Falconi R Comp Biochem Physiol B Biochem Mol Biol; 2009 Nov; 154(3):341-5. PubMed ID: 19665574 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of dipeptidyl peptidase IV enzyme activity in the American crocodile (Crocodylus acutus). Merchant M; Mead S; McAdon C; McFatter J; Wasilewski J Vet Immunol Immunopathol; 2010 Jul; 136(1-2):28-33. PubMed ID: 20227771 [TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury. Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site. Kühn-Wache K; Bär JW; Hoffmann T; Wolf R; Rahfeld JU; Demuth HU Biol Chem; 2011 Mar; 392(3):223-31. PubMed ID: 21284559 [TBL] [Abstract][Full Text] [Related]
11. The scientific evidence: vildagliptin and the benefits of islet enhancement. Mathieu C Diabetes Obes Metab; 2009 May; 11 Suppl 2():9-17. PubMed ID: 19385979 [TBL] [Abstract][Full Text] [Related]
12. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884 [TBL] [Abstract][Full Text] [Related]
13. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Pipatpiboon N; Pintana H; Pratchayasakul W; Chattipakorn N; Chattipakorn SC Eur J Neurosci; 2013 Mar; 37(5):839-49. PubMed ID: 23240760 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the active metabolites in the inhibitory activity of K579 on rat plasma dipeptidyl peptidase IV. Takasaki K; Takada H; Nakajima T; Ueno K; Ushiki J; Higo K Eur J Pharmacol; 2004 Nov; 505(1-3):237-41. PubMed ID: 15556158 [TBL] [Abstract][Full Text] [Related]
15. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats. Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Frerker N; Wagner L; Wolf R; Heiser U; Hoffmann T; Rahfeld JU; Schade J; Karl T; Naim HY; Alfalah M; Demuth HU; von Hörsten S Peptides; 2007 Feb; 28(2):257-68. PubMed ID: 17223229 [TBL] [Abstract][Full Text] [Related]
17. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs. He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976 [TBL] [Abstract][Full Text] [Related]